We are live on ! Find out more
IUHSA

Itau Unibanco Holding S.A. Portfolio holdings

AUM $4.31B
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
-5.37%
1 Year Est. Return
+46.57%
3 Year Est. Return
+107.3%
5 Year Est. Return
+125.12%
10 Year Est. Return
+406.64%
AUM
$1.84B
AUM Growth
-$278M
Cap. Flow
-$132M
Cap. Flow %
-7.18%
Top 10 Hldgs %
57.02%
Holding
742
New
57
Increased
42
Reduced
66
Closed
444

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$36.6M
2
MSFT icon
Microsoft
MSFT
+$36M
3
AMX icon
America Movil
AMX
+$33.5M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$32M
5
BABA icon
Alibaba
BABA
+$28.2M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$49.3M
2
ITUB icon
Itaú Unibanco
ITUB
+$23.9M
3
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$22.5M
4
BBD icon
Banco Bradesco
BBD
+$18.5M
5
PBR.A icon
Petrobras Class A
PBR.A
+$18.5M

Sector Composition

Rank Sector Weight
1 Financials 26.2%
2 Energy 8.78%
3 Technology 6.37%
4 Consumer Discretionary 5.91%
5 Materials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAM icon
276
Atlassian
TEAM
$37.5B
$13K ﹤0.01%
102
– –
WVE icon
277
Wave Life Sciences
WVE
$1.2B
$13K ﹤0.01%
487
– –
BOLD
278
DELISTED
Audentes Therapeutics, Inc
BOLD
$13K ﹤0.01%
336
– –
ALNY icon
279
Alnylam Pharmaceuticals
ALNY
$29.3B
$12K ﹤0.01%
166
– –
CBIO
280
Crescent Biopharma
CBIO
$645M
$11K ﹤0.01%
9
– –
MYOV
281
DELISTED
Myovant Sciences Ltd.
MYOV
$11K ﹤0.01%
1,220
– –
MNTA
282
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11K ﹤0.01%
+921
New +$11.1K
MLM icon
283
Martin Marietta Materials
MLM
$33B
$10K ﹤0.01%
+44
New +$10.9K
BCEL
284
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$10K ﹤0.01%
513
– –
KPTI icon
285
Karyopharm Therapeutics
KPTI
$44.2M
$9K ﹤0.01%
96
– –
CTMX icon
286
CytomX Therapeutics
CTMX
$750M
$8K ﹤0.01%
756
– –
HRTX icon
287
Heron Therapeutics
HRTX
$71M
$8K ﹤0.01%
423
– –
ALDR
288
DELISTED
Alder Biopharmaceuticals
ALDR
$7K ﹤0.01%
618
– –
KALA icon
289
KALA BIO
KALA
$15.3M
– –
0
– –
PHAS
290
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6K ﹤0.01%
432
– –
CME icon
291
CME Group
CME
$96B
$5K ﹤0.01%
+10,000
New +$2.09M
OGE icon
292
OGE Energy
OGE
$9.58B
$5K ﹤0.01%
100
-24,020
-100% -$1.04M
RIGL icon
293
Rigel Pharmaceuticals
RIGL
$770M
$5K ﹤0.01%
189
– –
ASMB icon
294
Assembly Biosciences
ASMB
$530M
$4K ﹤0.01%
24
– –
RCUS icon
295
Arcus Biosciences
RCUS
$3.66B
$4K ﹤0.01%
464
– –
CALA
296
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
34
– –
JNCE
297
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2K ﹤0.01%
380
– –
NTGN
298
CALL
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$2K ﹤0.01%
+335
New +$1.02K
A icon
299
CALL
Agilent Technologies
A
$41.9B
– –
-279
Closed -$1K
ABBV icon
300
AbbVie
ABBV
$435B
– –
-3,949
Closed -$287K
10 11
12
13 14

Similar funds

MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Itau Unibanco Holding S.A.'s Q3 2019 Portfolio in Review

As of Q3 2019, Itau Unibanco Holding S.A. held 742 positions worth $1.84B, down 13% from $2.12B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Itau Unibanco Holding S.A. withdrew a net $132M in Q3 2019, closing 444 positions and reducing 66 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 30% a quarter earlier, followed by Energy and Technology.

Against the trend, Itau Unibanco Holding S.A. opened a new position in iShares MSCI EAFE ETF worth $37M.

  • Itau Unibanco Holding S.A.'s largest Q3 2019 buy was iShares MSCI EAFE ETF: 568,070 shares worth $37M.
  • Itau Unibanco Holding S.A. added most to Microsoft in Q3 2019, an estimated $36M increase.
  • Itau Unibanco Holding S.A.'s biggest Q3 2019 reduction was Itaú Unibanco, cutting an estimated $23.9M.
  • Itau Unibanco Holding S.A. fully exited iShares MSCI Emerging Markets ETF in Q3 2019, selling an estimated $49.3M.
  • Itau Unibanco Holding S.A.'s ten largest holdings make up 57% of its $1.84B portfolio in Q3 2019.
  • Itau Unibanco Holding S.A. opened 57 new positions and closed 444 in Q3 2019.
  • Itau Unibanco Holding S.A.'s portfolio value fell 13% quarter-over-quarter to $1.84B.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.